Funds and ETFs Coloplast A/S

Equities

COLO B

DK0060448595

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Copenhagen 10:59:45 2024-04-26 EDT 5-day change 1st Jan Change
863.4 DKK -0.09% Intraday chart for Coloplast A/S -4.70% +11.84%

ETFs positioned on Coloplast A/S

Name Weight AuM 1st Jan change Investor Rating
1.81% 192 M€ +13.43%
1.11% 267 M€ +5.99%
0.96% 49 M€ +5.28%
0.85% 3 M€ +9.95% -
0.58% 18 M€ +3.79% -
0.33% 1,120 M€ +0.40%
0.28% 88 M€ +10.37% -
0.19% 6 M€ -.--% -
0.18% 4 M€ -.--% -
0.17% 6 M€ -.--%
0.17% 7 M€ +1.95% -
0.14% 3,859 M€ +18.82% -
0.14% 469 M€ -2.05% -
0.08% 10 M€ -3.35% -
0.07% 276 M€ +11.40% -
0.06% 277 M€ -.--% -
0.06% 194 M€ +7.48% -
0.06% 441 M€ +10.26%
0.04% 284 M€ -.--%
0.03% 273 M€ +15.83%
0.03% 206 M€ -.--%
0.03% 0 M€ 0.00% -
0.03% 23 M€ -.--% -
0.03% 786 M€ -.--%
0.03% 1,166 M€ +0.26% -
0.03% 607 M€ +0.05% -
0.02% 389 M€ +6.83% -
0.02% 34 M€ +6.71% -
Coloplast A/S specializes in the design, manufacturing, and marketing of disposable medical products. Net sales break down by family of products as follows: - hygiene products (43.4%): urine bags, plugs, urinary testing systems and sets, etc.; - ostomy care products (36.8%): bags and equipment used following intestinal operations; - wound care and skincare products (11.9%): wound dressings, bandages, creams and gels; - voice and respiratory care products (7.9%): voice prostheses for speaking, adhesives, laryngectomy cannulas for breathing, hands-free speaking devices, etc. Net sales are distributed geographically as follows: Denmark (1.4%), the United States (21%), the United Kingdom (14%), France (10.8%) and other (52.8%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
863.4 DKK
Average target price
917.1 DKK
Spread / Average Target
+6.21%
Consensus
  1. Stock Market
  2. Equities
  3. COLO B Stock
  4. Funds and ETFs Coloplast A/S